3 Stocks Yielding Triple the S&P 500 to Buy in November

The article highlights PepsiCo (4.2% forward yield), Altria (nearly 5.8%), and Enbridge (5.6%) as income alternatives to the S&P 500's 1.1% trailing yield, citing dividend increases of 54, 61, and 31 consecutive years, respectively. PepsiCo's organic revenue rose 3.1% in Q3 and its shares rebounded 12% since reporting; Altria's organic revenue rose more than 3% and earnings per share increased 5.1% through the first three quarters of 2026 despite cigarette volumes falling nearly 3%. Enbridge's fee-based pipelines support dividends while it invests in wind and solar projects; the article frames the companies as high-yield options while noting long-term tobacco and fossil-fuel transition risks.

Analysis

Treat the quoted yields as compensation for distinct risks, not a comparable income screen. PEP’s rebound may already price in a cleaner turnaround: the key test is whether organic growth converts into sustained volume/mix and margin improvement, rather than relying on price increases. KO’s premium could persist if investors continue to pay for perceived defensive earnings, but the yield gap alone does not establish relative value. A PEP/KO pair is therefore a momentum-versus-quality trade, not an obvious convergence trade.

MO’s cash generation can outlast cigarette volumes, but rising prices and earnings per share do not prove that newer nicotine products can replace a shrinking combustible base. Regulatory limits on products or marketing could accelerate that gap; a dividend record is not protection against a deteriorating payout base. ENB’s fee-based model reduces direct commodity-price sensitivity, not exposure to throughput, contract renewals, counterparty credit, financing costs, or project execution. Its renewable investments are optionality, not yet evidence of a material earnings transition.

Near term, dividend-seeking flows and recent PEP momentum may support the group. Over 1–3 months, earnings updates on volumes, margins, payout coverage and financing are the useful catalysts. Over 6–18 months, the central divergence is whether PEP restores profitable growth, MO replaces declining cigarette economics, and ENB funds transition capex without weakening distribution coverage. The source provides no valuation, payout-coverage, or debt-cost detail; verify these before sizing income exposure.

Key Decisions for Investors

• PEP: Do not chase the post-results rebound on yield alone. Reassess after the next earnings update; require evidence of volume/mix and margin progress alongside organic sales growth. Falsifier: growth remains price-led while volumes or profitability weaken.
• KO/PEP: Consider a small, risk-defined long KO / short PEP relative-value position only if the objective is to fade PEP’s rebound and favor defensive quality—not as a yield-arbitrage trade. Revisit if PEP delivers sustained operating improvement or KO’s premium narrows without deterioration in its fundamentals.
• MO: Treat the high yield as a risk signal as well as income. Keep exposure limited until product-level growth, cigarette-volume trends, dividend coverage and regulatory developments are checked. Reduce or avoid if earnings growth no longer offsets volume declines or payout coverage deteriorates.
• ENB: Monitor rather than buy solely for the stated yield. Before adding, verify distribution coverage, leverage/refinancing exposure, contracted volume and renewable-project funding. Reassess on material changes in rates, project costs, or pipeline utilization; fee-based revenue does not eliminate those risks.